Adjunctive use of platelet glycoprotein IIb/IIIa inhibitors for carotid angioplasty and stent placement: Time to say good bye?

Journal of Endovascular Therapy

Volumn 10, Issue 1, 2003, Pages 42-44

  Qureshi, Adnan I ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; LAMIFIBAN; TIROFIBAN;

ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; DRUG HALF LIFE; DRUG MECHANISM; HIGH RISK PATIENT; HUMAN; NEUROLOGICAL COMPLICATION; NOTE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STENT; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK;

ANGIOPLASTY; ANTIBODIES, MONOCLONAL; CAROTID STENOSIS; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PEPTIDES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE COMPLICATIONS; STENTS; TREATMENT OUTCOME; TYROSINE;

EID: 0038012892     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2003)010<0042:AUOPGI>2.0.CO;2     Document Type: Note

References (16)

1. Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II Clinical aspects and recommendations. Neurosurgery. 2000;46:1360-1375.
2. Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I Pathophysiological and pharmacological features. Neurosurgery. 2000;46:1344-1359.
3. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigators. N Engl J Med. 1994;330:956-961.
4. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG investigators. N Engl J Med. 1997;336:1689-1696.
5. Qureshi AI, Suri MF, Khan J, et al. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery. 2000;46:1316-1324.
6. Qureshi AI, Ali Z, Suri MF, et al. Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement. Neurosurgery. 2001;48:998-1004.
7. Arab D, Yahia AM, Qureshi AI. Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement. Int J Cardiovasc Intervent. 2003; in press.
8. Kapadia SR, Bajzer CT, Ziada KM, et al. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke. 2001;32:2328-2332.
9. Qureshi AI, Suri MF, Ali Z, et al. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002;50:466-475.
10. Wholey MH, Wholey MH, Eles G, et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther. 2003;10:000-000.
11. Hofmann R, Kerschner K, Steinwender C, et al. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: a randomized study. Stroke. 2002;33:725-727.
12. Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916-1919.
13. Akkerhuis KM, Deckers JW, Lincoff AM, et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA. 2001;286:78-82.
14. Meyers PM, Higashida RT, Phatouros CC, et al. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of craniocervical arteries. Neurosurgery. 2000;47:335-343.
15. Piepgras DG, Morgan MK, Sundt TM Jr, et al. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg. 1988;68:532-536.
16. Ouriel K, Shortell CK, Illig KA, et al. Intracerebral hemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. J Vasc Surg. 1999;29:82-87.